Martin Pan is currently the Executive Director of Global Medical Affairs specializing in Alzheimer's Disease and Neurodegeneration at Eli Lilly, presenting over 20 years of clinical and research experience in the pharmaceutical industry. Previously, Martin held key roles at Biogen, Amgen, and H. Lundbeck A/S, where they contributed significantly to projects in neuroscience, oncology, and infectious diseases, including the launch of seven therapeutic compounds across various therapeutic areas. Martin's educational background includes advanced degrees in Clinical Pharmacology, Pharmacology, and an MD from prestigious institutions in Spain. As a proactive networker with strong negotiation skills, Martin has been instrumental in establishing industrial-academic consortia and research collaborations. In their personal time, Martin enjoys rowing, jazz music, sailing, ski touring, and experimenting with new recipes.
This person is not in any teams
This person is not in any offices